KOSDAQ · Healthcare · ₩96B
₩3,080+0.98%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 2.3% · as of 26.10.26
Among 34 바이오 peers
Quarterly Revenue Growth
“이번 분기는 진단사업 기반 위에 신약 상용화 검증을 더하는 시기예요.”
In the company's words · 2026 2분기 filing